AITL has been characterized by recurrent mutations in genes of epigenome regulators (TET2, DNMT3A, and IDH2R172) as well as the proximal TCR and costimulatory signaling pathways [6]. The gene discussed is TET2; the disease is angioimmunoblastic T-cell lymphoma.